Nationwide Treatment Outcomes of Patients With Multidrug/Rifampin-Resistant Tuberculosis in Korea, 2011–2017: A Retrospective Cohort Study (Korean TB-POST)
Open Access
- 1 January 2023
- journal article
- research article
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (5) , e33
Abstract
Choi H, et al. J Korean Med Sci. 2023 Jan;38(5):e33. https://doi.org/10.3346/jkms.2023.38.e33Keywords
Funding Information
- Ministry of Health and Welfare (NC19-002, NC20-003, NC21-001)
- Korea Health Industry Development Institute (HI19C1235)
- Korean National Tuberculosis Association
This publication has 28 references indexed in Scilit:
- Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort studyThe Lancet Respiratory Medicine, 2018
- Tuberculosis, social determinants and co-morbidities (including HIV)Pulmonology, 2018
- Tuberculosis Notification Completeness and Timeliness in the Republic of Korea During 2012–2014Osong Public Health and Research Perspectives, 2016
- Does tuberculosis threaten our ageing populations?BMC Infectious Diseases, 2016
- Choice between Levofloxacin and Moxifloxacin and Multidrug-Resistant Tuberculosis Treatment OutcomesAnnals of the American Thoracic Society, 2016
- Tuberculosis among older adults – time to take noticeInternational Journal of Infectious Diseases, 2015
- Beyond UHC: Monitoring Health and Social Protection Coverage in the Context of Tuberculosis Care and PreventionPLOS Medicine, 2014
- Diagnostic Accuracy of Notified Cases as Pulmonary Tuberculosis in Private Sectors of KoreaJournal of Korean Medical Science, 2012
- Tuberculosis and noncommunicable diseases: neglected links and missed opportunitiesEuropean Respiratory Journal, 2010
- Treatment Outcomes and Long-term Survival in Patients with Extensively Drug-resistant TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2008